Clinical pharmacy services to improve management outcomes of Chronic Kidney Disease of uncertain etiology

Not Applicable

• Conditions: Chronic Kidney Disease of uncertain etiology

• Registration Number: SLCTR/2015/030
• Lead Sponsor: ational Research Council

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 20 August 2024

Recruitment & Eligibility

• Status: Complete: follow up complete
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

1. Consenting adults age over 18 years
2. Established diagnosis of Stage 3 or 4 Chronic Kidney Disease of Uncertain etiology

Exclusion Criteria

1. Patients undergoing haemodialysis at recruitment
2. Patients with a history of renal transplantation
3. Patients who do not give consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Drug adherence as measured by the brief medication questionnaire: A tool for screening patient adherence and barriers to adherence (Svarstad et al., 1999) [1.At the date of recruitment (baseline) and 12 months after the date of recruitment (post research)<br>]<br>

Secondary Outcome Measures

Name	Time	Method
1. Blood Pressure <br>2. Blood investigations: hemoglobin, serum calcium, serum phosphate, serum creatinine, serum electrolytes <br>3. Quality of life as measured by Kidney Disease Quality of Life Short Form (KDQOL-SF<sup>TM</sup>), Version 1.3. (Hays et al, 1995).<br> [1. At the date of recruitment (baseline) and 12 months after the date of recruitment (post research) <br>2. At the date of recruitment (baseline) and 12 months after the date of recruitment (post research) <br>3.At the date of recruitment (baseline) and 12 months after the date of recruitment (post research)<br><br><br>]<br>